does glp 1 cause heart problems GLP-1 Agonists and Rate Mechanisms of GLP-1 Receptor Agonists

PLoS One 8, e67541 (2013)

& Schindelin, H

no inbound file links

doi: 10.1007/s12072-008-9112-z 101 LinSYCMagalisBRSalemiMLiuHF

Regular follow-up during treatment is also crucial for monitoring any adverse effects and adjusting the regimen as needed

CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days